FP7
COMPACT
Collaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 60 months
- Total cost
- EUR 29,983,730
- EU contribution
- EUR 10,184,909
- Participants
- 21 from 11 countries
- Topic
- FP7_IMI-JU-04-2011-03
- Grant agreement
- 115363
Coordinated by Sanofi-Aventis Deutschland GmbH (DEGermany).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Sanofi-Aventis Deutschland GmbH | DEGermany | Coordinator | Not stated | PIC (1.00) |
| Universitat Wien | ATAustria | Participant | EUR 837,742 | known name (0.95) |
| Universiteit Gent | BEBelgium | Participant | EUR 491,133 | known name (0.95) |
| Universitat Zurich | CHSwitzerland | Participant | EUR 612,981 | known name (0.95) |
| Abbvie Deutschland GmbH & Co KG | DEGermany | Participant | Not stated | PIC (1.00) |
| Boehringer Ingelheim Internationalgmbh | DEGermany | Participant | Not stated | PIC (1.00) |
| Helmholtz-Zentrum Fur Infektionsforschung GmbH | DEGermany | Participant | EUR 550,611 | known name (0.97) |
| Ludwig-Maximilians-Universitaet Muenchen | DEGermany | Participant | EUR 201,594 | PIC (1.00) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | Not stated | PIC (1.00) |
| Bioneer A/S | DKDenmark | Participant | EUR 487,563 | PIC (1.00) |
| Kobenhavns Universitet | DKDenmark | Participant | EUR 984,291 | known name (0.95) |
| Novo Nordisk A/S | DKDenmark | Participant | Not stated | PIC (1.00) |
| Helsingin Yliopisto | FIFinland | Participant | EUR 444,273 | known name (0.95) |
| Cardiff University | GBUnited Kingdom | Participant | EUR 675,228 | known name (0.95) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| The Chancellor, Masters and Scholars of the University of Oxford | GBUnited Kingdom | Participant | EUR 731,618 | PIC (1.00) |
| Pharmacoidea Fejleszto Es Szolgaltato Kft | HUHungary | Participant | EUR 559,740 | PIC (1.00) |
| Universiteit Leiden | NLNetherlands | Participant | EUR 786,582 | known name (0.95) |
| Universiteit Utrecht | NLNetherlands | Participant | EUR 1,712,509 | known name (0.95) |
| Norges Teknisk-Naturvitenskapelige Universitet Ntnu | NONorway | Participant | EUR 491,014 | known name (0.95) |
| Stockholms Universitet | SESweden | Participant | EUR 618,030 | known name (0.95) |
Changes of the consortium
First seen on with 21 participants from 11 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.